Tumor M2-PK

Translational Medicine is a rapidly growing discipline in biomedical research and aims to expedite the discovery of new diagnostic tools and treatments by using a multi-disciplinary, highly collaborative, "bench-to-bedside" approach.

Overview

Within the public health context, the goal of translational medicine is to combine disciplines, resources, expertise, and techniques within these pillars to promote enhancements in prevention, diagnosis, and therapies. Accordingly, the National Institutes of Health (NIH) has made a significant investment in translational medicine, particularly through its Clinical and Translational Science Award (CTSA) program.

Bench to Bedside

The concept of "bench to bedside" is a way of conveying the notion of translational medicine. The idea is that basic science research at the "bench" leads to findings that can be developed into clinical applications for patients at the "bedside". This process often involves animal models or human clinical trials.

Clinical and Translational Science Award (CTSA)

The Clinical and Translational Science Award (CTSA) program is a consortium led by the National Institutes of Health's National Center for Advancing Translational Sciences (NCATS). The CTSA program aims to improve human health by streamlining science, transforming training environments, and improving the conduct, quality, and dissemination of clinical and translational research.

Challenges

Despite the promise of translational medicine, there are significant challenges to its full implementation. These include the need for more and better collaboration between basic scientists and clinicians, the need for more funding, and the need for better training and education in translational medicine.

See Also

• Clinical Research
• Public Health
• National Institutes of Health
• Clinical and Translational Science Award

Tumor M2-PK Resources
Latest articles Most recent articles Ongoing trials	Wikipedia